Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Osman M. Mansour"'
Autor:
Sohier A. Maksoud, Heba A. Razik, Naglaa Kholoussi, Amr Kh, Shahera A. Zayed, Somai Ismail, Osman M. Mansour, Raina Kandil, Haiam Abdel Raouf
Publikováno v:
Middle East Journal of Medical Genetics. 5:60-64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0634ce5f00d36f7e40bbc3c23816aa6d
https://doi.org/10.1097/01.mxe.0000484371.78522.fd
https://doi.org/10.1097/01.mxe.0000484371.78522.fd
Autor:
Moustafa M, El Serafi, Ahmed I, El Khodary, Heba R, El Zawahry, Osman M, Mansour, Hussein E, Gaballa
Publikováno v:
Journal of the Egyptian National Cancer Institute. 18(3)
Doxorubicin and Gemcitabine have promising antineoplastic activity and manageable toxicity as a single agent in the treatment of patients (pts) with advanced breast cancer.This study evaluated the efficacy and toxicity of the combination of gemcitabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5144c636cfb566380cb6fea5fd707b86
https://pubmed.ncbi.nlm.nih.gov/17671530
https://pubmed.ncbi.nlm.nih.gov/17671530
Autor:
LISIŃSKA-KUŚNIERZ, Małgorzata, KRUPA, Michał, PAPRZYCA, Krystyna, SYGUŁA-CHOLEWIŃSKA, Justyna, KUŚNIERZ, Kazimierz, IVASHKO, Oleksandr
Publikováno v:
International Journal of Conservation Science; Oct-Dec2020, Vol. 11 Issue 4, p905-916, 12p
Publikováno v:
International Journal of Conservation Science; Jul-Sep2019, Vol. 10 Issue 3, p459-474, 16p
Publikováno v:
International Journal of Conservation Science; Oct-Dec2017, Vol. 8 Issue 4, p619-632, 14p
Autor:
Zayed, Shahera A., Mansour, Osman M., Kholoussi, Naglaa M., Razik, Heba A., Kh, Amr, Maksoud, Sohier A., Raouf, Haiam Abdel, Ismail, Somai, Kandil, Raina
Publikováno v:
Middle East Journal of Medical Genetics; Jul2016, Vol. 5 Issue 2, p60-64, 5p
Autor:
Ibrahim Malash, Nasr Allahloubi, Abeer A. Bahnasy, Sabry Shaarawy, Osman Mansour, Rabab Gaafar
Publikováno v:
Cancer Research. 75:P2-05
Background: Acquisition of resistance to tamoxifen remains a major drawback in the treatment of oestrogen receptor (ER)-positive breast cancers. Aberrant expressions of some genes in the EGFR pathway were associated to the acquisition of resistance i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79bb085a69a8d9b6638538d4ebe00eab
https://doi.org/10.1158/1538-7445.sabcs14-p2-05-11
https://doi.org/10.1158/1538-7445.sabcs14-p2-05-11